Inventiva (IVA) Accumulated Expenses (2022 - 2025)
Inventiva (IVA) recorded quarterly Accumulated Expenses of $1.9 million in Q2 2025, down 31.5% quarter-over-quarter from $2.8 million in Q4 2024, and up 234.92% on a YoY basis from $569160.8 in Q2 2024.
Inventiva (IVA) Accumulated Expenses (2022 - 2025) Analysis & Trends
Inventiva's Accumulated Expenses history runs 4 years deep, the most recent figure standing at $1.9 million for Q2 2025.
- In Q2 2025, Accumulated Expenses rose 234.92% year-over-year to $1.9 million; the TTM figure through Jun 2025 stood at $1.9 million (up 234.92% YoY), while the FY2024 annual figure was $2.8 million, up 38.37% from the prior year.
- Accumulated Expenses was $1.9 million for Q2 2025 at Inventiva, down from $2.8 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $2.8 million in Q4 2024 to a low of -$1.4 million in Q2 2024.
- Historically, Accumulated Expenses has averaged $1.2 million across 4 years, with a median of $1.9 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses tumbled 12874.97% in 2024, then soared 234.92% in 2025.
- A 4-year view of Accumulated Expenses shows it stood at $1.9 million in 2022, then climbed by 5.63% to $2.0 million in 2023, then surged by 38.37% to $2.8 million in 2024, then tumbled by 31.5% to $1.9 million in 2025.
- The last three Accumulated Expenses figures came in at $1.9 million (Q2 2025), $2.8 million (Q4 2024), and -$1.4 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Inventiva | 8.64 Mn | -260.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.91 Mn |
| Dec 31, 2024 | 2.78 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Jun 30, 2023 | -10,889.24 |
| Dec 31, 2022 | 1.90 Mn |